An experimental Ebola drug called ZMapp, made by U.S. biotech company Mapp Biopharmaceutical, was given to two American health workers infected with Ebola in Liberia
Liberia said on Tuesday it would treat two infected doctors with the scarce experimental Ebola drug ZMapp, the first Africans to receive the treatment, while authorities in Spain said a 75-year-old priest had died of the disease.
The death toll from the worst ever outbreak of the highly contagious disease has climbed to 1,013 since it was discovered in remote southeastern Guinea in March, according to the World Health Organization (WHO).
It said ZMapp doses were very scarce, raising ethical questions of who should have priority.
Spanish authorities said a 75-year-old Spanish priest who.......Read complete story here
No comments:
Post a Comment
Thanks for stopping by.Drop your comments